ArticleJournal of veterinary internal medicine2026
Management of carbapenem-resistant Enterobacterales in a veterinary hospital environment utilizing surveillance with infection control and prevention measures.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur program was initiated to manage an unexpected increase in carbapenem-resistant Enterobacterales (CRE) contamination identified during routine environmental surveillance in the small animal intensive care unit (ICU) at The Ohio State University Veterinary Medical Center (VMC). Addressing CRE, an urgent public health threat, was critical to protect patients and veterinary personnel. HYPOTHESIS/
objectivesDesign an active surveillance program to guide infection control and prevention (ICP) measures and successfully manage CRE in the VMC environment.
methodsThe VMC's environmental surveillance program has conducted monthly surveillance since 2018 to identify pathogens, including CRE. In response to increased CRE contamination in September 2023, a CRE Response Plan Working Group developed and implemented a plan to control contamination and prevent disease transmission. Interventions included enhanced surveillance, strengthened ICP measures, updated CRE protocols, improved cleaning and disinfection, hand hygiene audits and education, ICP training, and a unified communication strategy.
resultsWeekly environmental surveillance identified 4 repeatedly CRE-contaminated surfaces: the covered outdoor run, the emergency room and ICU hallway floors, and the ICU medication preparation counter and CUBEX machine. One patient with a clinical CRE infection was managed without any further identified transmission. By January 2024, repeated CRE contamination was no longer detected in the VMC. Screening ICU patients for CRE fecal colonization identified a 1.9% prevalence. CONCLUSIONS AND CLINICAL IMPORTANCE: Active environmental surveillance enabled early detection of increased CRE contamination which guided ICP measures, decreasing the risk of CRE transmission. We provide a framework for responding to nosocomial threats in veterinary hospital settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.